Rashi Anand, | |
10515 N Mopac Expy Ste A120, Austin, TX 78759-5477 | |
(512) 348-2806 | |
Not Available |
Full Name | Rashi Anand |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 10515 N Mopac Expy Ste A120, Austin, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407429210 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 28443 (Maryland) | Secondary |
225100000X | Physical Therapist | 1370568 (Texas) | Primary |
Entity Name | Agilitas Usa Inc |
---|---|
Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Entity Identifiers | NPI Number: 1962417444 PECOS PAC ID: 3375454648 Enrollment ID: O20160425001328 |
News Archive
Themis announced today that the European Medicines Agency has granted PRIority MEdicines designation to its most advanced program in development, a vaccine to prevent chikungunya fever.
A recent report on reducing harm from alcohol by the Government's strategy unit has been 'neutered' in comparison with the same study's interim findings, according to an editorial in this week's BMJ.
In a landmark study, researchers found that patients treated with paramedic oxygen delivery using a newer, more flexible laryngeal breathing tube may have a greater survival rate after sudden cardiac arrest than the traditional intubation breathing tube.
A protein related to aggressive cancers can actually improve the efficacy of gemcitabine at treating pancreatic cancer, according to a Priority Report in Cancer Research, published by researchers at Thomas Jefferson University.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Rashi Anand, 1200 Corporate Dr Ste 400, Hoover, AL 35242-5424 Ph: () - | Rashi Anand, 10515 N Mopac Expy Ste A120, Austin, TX 78759-5477 Ph: (512) 348-2806 |
News Archive
Themis announced today that the European Medicines Agency has granted PRIority MEdicines designation to its most advanced program in development, a vaccine to prevent chikungunya fever.
A recent report on reducing harm from alcohol by the Government's strategy unit has been 'neutered' in comparison with the same study's interim findings, according to an editorial in this week's BMJ.
In a landmark study, researchers found that patients treated with paramedic oxygen delivery using a newer, more flexible laryngeal breathing tube may have a greater survival rate after sudden cardiac arrest than the traditional intubation breathing tube.
A protein related to aggressive cancers can actually improve the efficacy of gemcitabine at treating pancreatic cancer, according to a Priority Report in Cancer Research, published by researchers at Thomas Jefferson University.
› Verified 5 days ago